Key result
Mitral balloon valvuloplasty linked to a ~22% decrease in P-wave dispersion in rheumatic mitral stenosis.
Why the study?
Mitral stenosis is associated with increased P-wave dispersion, a marker of AF risk, but the immediate effect of successful PMBV on these parameters required evaluation.
Does percutaneous mitral balloon valvuloplasty (PMBV) improve P-wave dispersion in patients with rheumatic mitral stenosis?
Observational (n=130)
No
Does percutaneous mitral balloon valvuloplasty (PMBV) improve P-wave dispersion in patients with rheumatic mitral stenosis?
The study investigates whether successful percutaneous mitral balloon valvuloplasty immediately alters P-wave dispersion, an ECG marker of atrial fibrillation risk, in rheumatic mitral stenosis.
Answers are grounded in this paper and cite their sources.
PMBV was associated with reduced P-wave dispersion; hypothesis-generating for AF risk reduction, needs RCTs before practice change.
Introduction: P-wave dispersion (PWD) is a new electrocardiographic (ECG) index believed to reflect heterogeneous atrial conduction with ECG leads of different orientation. Mitral stenosis (MS) is associated with increased PWD, which are markers of atrial fibrillation (AF) risk. The aim of the present study was to assess the immediate effect of successful percutaneous mitral balloon valvuloplasty (PMBV) on these parameters.
No takes yet. Share an insight, caveat, or question.
Ağuş et al. (2018) conducted an observational in Rheumatic Mitral Stenosis (n=130). Percutaneous mitral balloon valvuloplasty (PMBV) vs. Pre-PMBV baseline and healthy controls was evaluated on P-wave dispersion (PWD) in ms (p=<0.001). Percutaneous mitral balloon valvuloplasty decreased P-wave dispersion from a median of 45 ms to 35 ms within 72 hours in patients with rheumatic mitral stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: